Kai Hu

911 total citations
32 papers, 560 citations indexed

About

Kai Hu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Kai Hu has authored 32 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 6 papers in Oncology. Recurrent topics in Kai Hu's work include Neuroscience and Neuropharmacology Research (6 papers), Retinal Diseases and Treatments (3 papers) and CAR-T cell therapy research (3 papers). Kai Hu is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Retinal Diseases and Treatments (3 papers) and CAR-T cell therapy research (3 papers). Kai Hu collaborates with scholars based in China, United States and Canada. Kai Hu's co-authors include Xiangchang Zeng, Dongsheng Ouyang, Guo‐li Ming, Xiaohui Li, Jian Xiao, Bo Xiao, Xiaoyan Long, Yi Li, Li Feng and Lili Long and has published in prestigious journals such as Advanced Materials, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Kai Hu

26 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Hu China 14 268 132 93 60 60 32 560
Shanying Huang China 15 300 1.1× 75 0.6× 82 0.9× 103 1.7× 49 0.8× 30 610
Guangchun Sun China 17 464 1.7× 96 0.7× 148 1.6× 57 0.9× 54 0.9× 30 768
Rong Ma China 9 200 0.7× 89 0.7× 110 1.2× 153 2.5× 64 1.1× 21 495
Zijian Li China 11 393 1.5× 132 1.0× 32 0.3× 84 1.4× 61 1.0× 15 645
Yiye Shao China 14 332 1.2× 232 1.8× 86 0.9× 47 0.8× 74 1.2× 22 635
Lanqiu Zhang China 17 318 1.2× 66 0.5× 54 0.6× 46 0.8× 63 1.1× 38 714
Wenjuan He China 14 315 1.2× 90 0.7× 97 1.0× 73 1.2× 172 2.9× 42 676
Qing Ye China 15 183 0.7× 49 0.4× 41 0.4× 81 1.4× 52 0.9× 35 516

Countries citing papers authored by Kai Hu

Since Specialization
Citations

This map shows the geographic impact of Kai Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Hu more than expected).

Fields of papers citing papers by Kai Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Hu. The network helps show where Kai Hu may publish in the future.

Co-authorship network of co-authors of Kai Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Hu. A scholar is included among the top collaborators of Kai Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Hu. Kai Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hu, Kai, Linlin Liang, & Jian Song. (2025). Development of a ROS-responsive, glutathione-functionalized injectable hydrogel system for controlled drug release. Journal of Biomaterials Applications. 40(2). 181–191.
3.
Liu, Haidi, Sun Meiling, Rui Liu, et al.. (2025). Chimeric antigen receptor (CAR) -T cell therapy treatment Richter's transformation. Frontiers in Oncology. 15. 1591360–1591360.
4.
Sui, Weiwei, et al.. (2024). BCMA CAR-T induces complete and durable remission in plasmablastic lymphoma synchronous transformation of chronic lymphocytic leukemia: Case report and literature review. Critical Reviews in Oncology/Hematology. 205. 104551–104551. 1 indexed citations
5.
Sun, Yujia, Kai Hu, Qingqing Li, et al.. (2024). Subthalamic nucleus dynamics track microlesion effect in Parkinson’s disease. Frontiers in Cell and Developmental Biology. 12. 1370287–1370287. 3 indexed citations
7.
Hu, Kai, Junlong Ma, Xin Huang, et al.. (2023). Association of Antipsychotic Drugs with Venous Thromboembolism: Data Mining of Food and Drug Administration Adverse Event Reporting System and Mendelian Randomization Analysis. Journal of Atherosclerosis and Thrombosis. 31(4). 396–418. 2 indexed citations
8.
Sun, Yujia, et al.. (2022). Separating the aperiodic and periodic components of neural activity in Parkinson's disease. European Journal of Neuroscience. 56(6). 4889–4900. 26 indexed citations
9.
Yan, Yi, et al.. (2021). Access to Endovascular Thrombectomy for Stroke in Rural Versus Urban Regions. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 49(1). 70–75. 9 indexed citations
10.
Sun, Yujia, et al.. (2021). α and θ oscillations in the subthalamic nucleus are potential biomarkers for Parkinson's disease with depressive symptoms. Parkinsonism & Related Disorders. 90. 98–104. 14 indexed citations
12.
Zhou, Luping, Lulu Chen, Yaqin Wang, et al.. (2018). Impact of NR1I2, adenosine triphosphate–binding cassette transporters genetic polymorphisms on the pharmacokinetics of ginsenoside compound K in healthy Chinese volunteers. Journal of Ginseng Research. 43(3). 460–474. 9 indexed citations
13.
Zeng, Xiangchang, Kai Hu, Lulu Chen, et al.. (2018). The Effects of Ginsenoside Compound K Against Epilepsy by Enhancing the γ-Aminobutyric Acid Signaling Pathway. Frontiers in Pharmacology. 9. 1020–1020. 32 indexed citations
14.
Han, Feng, Weihua Huang, Yingying Tian, et al.. (2017). Aucubin and its hydrolytic derivative attenuate activation of hepatic stellate cells via modulation of TGF-β stimulation. Environmental Toxicology and Pharmacology. 50. 234–239. 23 indexed citations
15.
Zeng, Xiangchang, Qing Gao, Wenjing Zong, et al.. (2017). The expression of G protein-coupled receptor kinase 5 and its interaction with dendritic marker microtubule-associated protein-2 after status epilepticus. Epilepsy Research. 138. 62–70. 4 indexed citations
16.
Ming, Guo‐li, et al.. (2016). NAMPT regulates senescence, proliferation, and migration of endothelial progenitor cells through the SIRT1 AS lncRNA/miR-22/SIRT1 pathway. Biochemical and Biophysical Research Communications. 478(3). 1382–1388. 55 indexed citations
17.
Ming, Guo‐li, Yongjun Tang, Kai Hu, et al.. (2016). Visfatin attenuates the ox-LDL-induced senescence of endothelial progenitor cells by upregulating SIRT1 expression through the PI3K/Akt/ERK pathway. International Journal of Molecular Medicine. 38(2). 643–649. 29 indexed citations
18.
Zhang, Mengqi, Yuanyuan Xie, Jian Xia, et al.. (2014). Synchrotron radiation imaging is a powerful tool to image brain microvasculature. Medical Physics. 41(3). 31907–31907. 20 indexed citations
19.
Hu, Kai, Chen Zhang, Lili Long, et al.. (2010). Expression profile of microRNAs in rat hippocampus following lithium–pilocarpine-induced status epilepticus. Neuroscience Letters. 488(3). 252–257. 89 indexed citations
20.
Song, Yanping, et al.. (2009). [Effects of recombinant human erythropoietin on hypoxia inducible factor-1alpha expression in the retina of rabbits with acute high intraocular pressure].. PubMed. 29(2). 271–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026